Even without COVID, those with STEMI during the pandemic faced a greater death risk ...

The buyout, which includes up to $2.15 billion in milestones, will give Bayer control of an eye disease implant that Perfuse ...

A California study found one in six MIs in younger adults were tied to meth use, many of them with nonobstructive CAD.

Immusoft of CA, a clinical-stage biotechnology company pioneering engineered B cell therapies, today announced that Scott McIvor, Chief Development Officer at Immusoft, will present recent clinical ...

Bayer and Perfuse Therapeutics Inc. today announced an agreement under which Bayer will fully acquire Perfuse Therapeutics, a biopharmaceutical company pioneering transformational research into the ...

Swedish registry follow-up of >5.3 million pre-pandemic and >5.5 million pandemic adults linked death of a partner, child, ...

Cancer patients who experience a recent financial hardship have an increased likelihood of spending more on health care at the end of life.

Support this channel by checking our NordVPN exclusive deal at <a ...

"Nobody but nobody can make it out here alone." In this powerful conversation, Oprah Winfrey shares how one teacher's ...

Patients with noncardioembolic ischemic stroke or transient ischemic attack (TIA) are at risk for recurrent stroke. Low factor XI levels are associated with a reduced risk of ischemic stroke.

Diabetes management often emphasizes the importance of weight loss, but this study suggests that thinner isn’t always better ...

According to the data presented, combination treatment of RZ-001 with atezolizumab and bevacizumab demonstrated an objective response rate (ORR) of 38.5% (confirmed) and 46.2% (unconfirmed) based on ...